PT  - JOURNAL ARTICLE
AU  - Boesen, K
AU  - Jørgensen, KJ
AU  - Gøtzsche, PC
TI  - Dose-response relationship of extended-release methylphenidate for ADHD in adults: post-hoc analysis based on a systematic review
AID  - 10.1101/2021.12.08.21267468
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.12.08.21267468
4099  - http://medrxiv.org/content/early/2021/12/09/2021.12.08.21267468.short
4100  - http://medrxiv.org/content/early/2021/12/09/2021.12.08.21267468.full
AB  - Objective To assess potential dose-response relationships of extended-release methylphenidate for ADHD in adults on efficacy outcomes.Study design and setting Post-hoc analysis based on a systematic review of extended-release methylphenidate (https://doi.org/10.1002/14651858.CD012857). Using data from clinical trials comparing multiple fixed-dose methylphenidate groups with placebo, we conducted subgroup meta-analyses for available efficacy outcomes.Results and conclusion Five trials used a fixed-dose design with multiple methylphenidate groups receiving different doses. All trials were pivotal industry sponsored studies conducted to obtain marketing authorisation. We analysed four efficacy outcomes: Selfrated ADHD symptoms (5 trials, 1807 participants), investigator-rated ADHD symptoms (5 trials, 1904 participants), quality of life (4 trials, 1158 participants), and peer-rated ADHD symptoms (2 trials, 879 participants). There were no dose-response relationships for any outcome.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe full dataset: https://osf.io/wrf65/?view_only=ef3340ea339c44bdad5f83732cf4ba84. https://osf.io/wrf65/?view_only=ef3340ea339c44bdad5f83732cf4ba84